Nurix

Scientist II, Degrader Antibody Conjugate Characterization

Nurix$140K — $161K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • PhD with 4+ years of industry experience in biochemistry or analytical chemistry.
  • Expertise in ADC/DAC characterization and method development.
  • Proficient in LCMS & HPLC methods specific to antibody and conjugate analysis.
  • Direct experience in ADC characterization and knowledge of conjugation chemistry.
  • Proven ability to design experiments, troubleshoot assays, and manage multiple programs.
  • Skilled in synthesizing complex data into actionable scientific insights.

Responsibilities

  • Design and execute the DAC screening characterization platform with robust quality criteria.
  • Present analytical findings and collaborate with cross-functional teams to streamline workflows.
  • Lead comprehensive analysis of antibodies and DACs, including detailed characterization methods.
  • Integrate analytical data into cohesive assessments to inform decision-making and quality thresholds.

Benefits

  • Working at the forefront of drug discovery and development in a novel therapeutic platform.
  • Opportunity to influence the analytical strategy and contribute to scientific advancements.
  • Collaborative work environment with multi-disciplinary teams.
  • Potential for professional growth in a dynamic research setting.
  • Emphasis on creativity, problem-solving, and continuous learning.
Full Job Description
Position

You will lead the development of innovative analytical workflows that support and accelerate Nurix's DAC platform, applying your expertise in ADC and/or DAC characterization to solve complex scientific challenges. This is an opportunity to shape analytical strategy for a novel therapeutic platform at the forefront of drug discovery and development.

This is a laboratory role requiring assay design, method development, hands-on execution, and scientific communication to project and platform teams. You will design and execute analytical strategies for high-throughput DAC screening, establish quality criteria that drive conjugate advancement decisions, and partner closely with conjugation chemistry, biology, and bioanalytical teams from early screening through candidate selection.

Responsiblities:
  • Design, execute and own the DAC screening characterization platform including DAR, aggregation, protein quantitation, and define the QC thresholds to advance conjugates for a program
  • Present findings to project and platform teams; collaborate with conjugation chemistry, bioanalytical, and cell screening groups to align workflows, coordinate sample flow, and influence conjugate advancement decisions
  • Lead and conduct in-depth characterization of antibodies and advanced DACs including positional isomers, glycosylation analysis, peptide mapping, and stability
  • Integrate DAR, purity, hydrophobicity, and stability data into unified assessments with QC cutoffs that drive go/no-go decisions; identify structure-quality trends across antibody, linker, and payload variables

Requirements:
  • PhD with 4+ years of industry experience in biochemistry, analytical chemistry, or a related discipline
  • Expertise in ADC/DAC & antibody characterization from method development to data interpretation
  • Expertise with LCMS & HPLC methods for antibody and conjugate analysis, including DAR, SEC, peptide mapping, HIC, and other relevant industry leading methods
  • Direct experience characterizing ADCs in an industry setting with working knowledge of conjugation chemistry, DAR heterogeneity, and common quality attributes
  • Track record of independently designing experiments, developing analytical methods, troubleshooting assay and instrument performance, and managing priorities across multiple concurrent programs
  • Ability to synthesize complex analytical datasets into actionable scientific conclusions and influence project decisions through clear communication to cross-functional teams

Preferred Qualifications
  • Experience with native LCMS, positional isomer analysis, glycan analysis, CE-SDS for expanded conjugate or antibody characterization
  • Background in peptide mapping, biophysical binding assays, and thermal stability
  • Familiarity with developability assessment, forced degradation, or formulation-support analytics for biologics
  • Familiarity & experience with Agilent instrumentation & analytical software (MassHunter, Byos, or equivalent)

Culture & Team Fit:
  • Ability to work collaboratively across multiple groups within the organization
  • Excellent organization and communication with effective presentation skills
  • Self-driven and enthusiastic with proficiencies to deliver in a dynamic environment
  • Curious mindset with a willingness and flexibility to learn new skills
  • High level of creativity and productivity with strong problem-solving skills

Salary Range: 140K - 161K

About Nurix

Nurix Therapeutics is a biotechnology company that is focused on the discovery, development, and commercialization of small molecule therapies that modulate the ubiquitin proteasome system (UPS) for the treatment of cancer and other diseases. The company's proprietary drug discovery platform is based on the use of DNA-encoded libraries (DELs) to identify small molecules that selectively bind to E3 ligases, which are key enzymes in the UPS. Nurix's lead drug candidate, NX-2127, is a first-in-class small molecule inhibitor of the CBL-B E3 ligase that is being developed for the treatment of solid tumors and hematological malignancies. The company was founded in 2013 and is headquartered in San Francisco, California.
Learn more about Nurix
Size
135 employees
Market Cap
$486 million
Industry
Net Income
-$43.2 million
Founded
2009
Revenue
$17.8 million
NASDAQ

Similar Jobs

More Jobs at Nurix

More Pharmaceuticals & Biotech Jobs

Find similar Scientist II, Degrader Antibody Conjugate Characterization jobs: